Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Closed Date7/2008

General Information

Offices

HQ
475 Armand-Frappier Blvd.
Laval, H7V 4B3, CAN

Funding

TOTAL $1.4M
FUNDING TOTAL $1.4M
Venture Round, 8/2009
Pappas Ventures
ProQuest Investments
Highland Capital Partners
Fonds de solidarité FTQ
$1.4M

Tags

Biosyntech Closed down July 23, 2008

Biosyntech

BioSyntech, Inc. develops biotherapeutic thermogels designed for tissue repair and delivery of therapeutic agents. Its technology platform is BST-Gel, a family of hydrogels based on chitosan, a natural biopolymer derived from crustacean shells. The company’s lead products in clinical trials include BSTCarGel for cartilage repair; BST-DermOn for wound healing; and BST-InPod for the treatment of chronic pain due to plantar fat pad atrophy in the heel and forefoot.

Biosyntech has a collaboration with Nicholas Piramal India, Ltd. to involve in the clinical studies for BST-InPod, which is being developed to alleviate the chronic pain associated with foot fat pads. The company was incorporated in 1994 and is headquartered in Laval, Canada.

Recent Milestones

  • Dollar
    Biosyntech received $1.4M in Venture Round funding. (8/14/09)
    Posted 9/29/09 at 6:43am via biosyntech.com
  • Check
    Closed. (7/23/08)
    Posted

Videos

Screenshots

Biosyntech screenshot
Above: Biosyntech Screenshot -- #1
Uploaded: 9/29/09

Sources

  1. BioSyntech Announces $4.5 Million Financing (biosyntech.com) [edit]
Edit This Page
Last Edited 10/9/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy